Table 1

Patient characteristics

Patient codeTumor typeNY-ESO-1 mRNA tumor expression*NY-ESO-1 antibody status*Preexisting CD8+ T cell responses to NY-ESO-1 peptidesVaccination protocol with NY-ESO-1 peptides
NW415MelanomaPositiveNegativeNoLUD97-008
NW886MelanomaPositiveNegativeNoLUD97-008
NW924MelanomaPositivePositiveYesLUD97-008
NW1288GastricPositivePositiveYesNone
NW1307SchwannomaPositivePositiveYesNone
109/ANSMelanomaPositiveNegativeNoLUD97-012
PI-E01NSCLCPositiveNegativeNoLUD00-019
ES-E03NSCLCPositiveNegativeNoLUD00-019
  • NSCLC, non small cell lung cancer. 

  • * NY-ESO-1 mRNA tumor expression and serum antibody detected as described (10).